[go: up one dir, main page]

DK1504098T3 - Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion - Google Patents

Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion

Info

Publication number
DK1504098T3
DK1504098T3 DK03722867T DK03722867T DK1504098T3 DK 1504098 T3 DK1504098 T3 DK 1504098T3 DK 03722867 T DK03722867 T DK 03722867T DK 03722867 T DK03722867 T DK 03722867T DK 1504098 T3 DK1504098 T3 DK 1504098T3
Authority
DK
Denmark
Prior art keywords
stranded polynucleotide
reaction
population
parent
polynucleotide molecules
Prior art date
Application number
DK03722867T
Other languages
English (en)
Other versions
DK1504098T4 (da
Inventor
Christina Furebring
Roland Carlsson
Carl Arne Krister Borrebaeck
Hager Ann-Christin Malmborg
Original Assignee
Alligator Bioscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29551433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1504098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0211369A external-priority patent/GB2388604B/en
Priority claimed from US10/321,195 external-priority patent/US7153655B2/en
Application filed by Alligator Bioscience Ab filed Critical Alligator Bioscience Ab
Publication of DK1504098T3 publication Critical patent/DK1504098T3/da
Application granted granted Critical
Publication of DK1504098T4 publication Critical patent/DK1504098T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK03722867.3T 2002-05-17 2003-05-16 Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion DK1504098T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211369A GB2388604B (en) 2002-05-17 2002-05-17 A method for in vitro molecular evolution of protein function
US10/321,195 US7153655B2 (en) 1998-06-16 2002-12-17 Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
PCT/GB2003/002102 WO2003097834A2 (en) 2002-05-17 2003-05-16 A method for in vitro molecular evolution of protein function

Publications (2)

Publication Number Publication Date
DK1504098T3 true DK1504098T3 (da) 2007-06-11
DK1504098T4 DK1504098T4 (da) 2011-05-23

Family

ID=29551433

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03722867.3T DK1504098T4 (da) 2002-05-17 2003-05-16 Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
DK200401821A DK200401821A (da) 2002-05-17 2004-11-23 Fremgangsmåde til in vitro molekylær udvikling af proteinfunktion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200401821A DK200401821A (da) 2002-05-17 2004-11-23 Fremgangsmåde til in vitro molekylær udvikling af proteinfunktion

Country Status (10)

Country Link
US (1) US7262012B2 (da)
EP (1) EP1504098B2 (da)
JP (1) JP4372679B2 (da)
AT (1) ATE356871T1 (da)
AU (1) AU2003230027A1 (da)
CA (1) CA2485506C (da)
DE (1) DE60312507T3 (da)
DK (2) DK1504098T4 (da)
ES (1) ES2285118T5 (da)
WO (1) WO2003097834A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333898A1 (en) * 1998-07-10 2000-01-20 Jari Pharmaceuticals B.V. Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
EP1586583A3 (en) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Compounds that block C5a complement receptor and their use in therapy
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0708376D0 (en) 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905503D0 (en) * 2009-03-31 2009-05-13 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0920258D0 (en) 2009-11-19 2010-01-06 Alligator Bioscience Ab New medical agents and use thereof
GB201019086D0 (en) 2010-11-11 2010-12-29 Imp Innovations Ltd Bacterial methods
US20140178921A1 (en) 2011-03-04 2014-06-26 Evolvemol, Inc. Apparatus and process for isolating specific physical items within a set of physical items
GB201115280D0 (en) 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
GB201311475D0 (en) 2013-06-27 2013-08-14 Alligator Bioscience Ab Polypeptides
EP3552665A3 (en) 2014-08-12 2019-12-18 Alligator Bioscience AB Antibodies
MX2018003905A (es) 2015-09-30 2018-09-06 Janssen Biotech Inc Anticuerpos agonistas que se unen específicamente a cd40 humana y métodos de uso.
CN113892654A (zh) * 2021-10-21 2022-01-07 长春大学 一种以绿豆蛋白粉为原料制备免消化绿豆蛋白质的方法

Family Cites Families (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888286A (en) 1984-02-06 1989-12-19 Creative Biomolecules, Inc. Production of gene and protein analogs through synthetic gene design using double stranded synthetic oligonucleotides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
WO1986005803A1 (fr) 1985-03-30 1986-10-09 Marc Ballivet Procede d'obtention d'adn, arn, peptides, polypeptides ou proteines, par une technique de recombinaison d'adn
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US4994368A (en) 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5043272A (en) 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5023171A (en) 1989-08-10 1991-06-11 Mayo Foundation For Medical Education And Research Method for gene splicing by overlap extension using the polymerase chain reaction
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
AU6886991A (en) 1989-11-08 1991-06-13 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A method of synthesizing double-stranded dna molecules
US5573907A (en) 1990-01-26 1996-11-12 Abbott Laboratories Detecting and amplifying target nucleic acids using exonucleolytic activity
EP0527809B1 (en) 1990-04-05 1995-08-16 CREA, Roberto Walk-through mutagenesis
AU7791991A (en) 1990-04-24 1991-11-11 Stratagene Methods for phenotype creation from multiple gene populations
US5387505A (en) 1990-05-04 1995-02-07 Eastman Kodak Company Preparation and isolation of single-stranded biotinylated nucleic acids by heat avidin-biotin cleavage
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5858725A (en) 1990-10-10 1999-01-12 Glaxo Wellcome Inc. Preparation of chimaeric antibodies using the recombinant PCR strategy
WO1992015702A1 (en) 1991-03-07 1992-09-17 Andrew Raymon Morton Bradbury The biological selection of useful molecules
DE4112440C1 (da) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
US5512463A (en) 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US5514568A (en) 1991-04-26 1996-05-07 Eli Lilly And Company Enzymatic inverse polymerase chain reaction
DE69230142T2 (de) 1991-05-15 2000-03-09 Cambridge Antibody Technology Ltd. Verfahren zur herstellung von spezifischen bindungspaargliedern
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US5223408A (en) 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
JP3540315B2 (ja) 1991-09-23 2004-07-07 メディカル リサーチ カウンシル キメラ抗体の製造−組合せアプローチ
US5521291A (en) 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
WO1993012257A1 (en) 1991-12-12 1993-06-24 Hybritech Incorporated Enzymatic inverse polymerase chain reaction library mutagenesis
US5395750A (en) 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
WO1994012632A1 (en) 1992-11-27 1994-06-09 University College London Improvements in nucleic acid synthesis by pcr
US5733753A (en) 1992-12-22 1998-03-31 Novo Nordisk A/S Amplification of genomic DNA by site specific integration of a selectable marker construct
US5491074A (en) 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
SE9304060D0 (sv) 1993-12-06 1993-12-06 Bioinvent Int Ab Sätt att selektera specifika bakteriofager
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
WO1996017056A1 (en) 1994-12-02 1996-06-06 Institut Pasteur Hypermutagenesis
ES2303338T3 (es) 1995-06-07 2008-08-01 Glaxo Group Limited Peptidos y compuestos que se unen a un receptor de trombopoyetina.
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP0843725B1 (en) 1995-08-11 2002-04-17 Novozymes A/S Method for preparing polypeptide variants
CA2229043C (en) 1995-08-18 2016-06-07 Morphosys Gesellschaft Fur Proteinoptimierung Mbh Protein/(poly)peptide libraries
US6479258B1 (en) 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
US6368798B1 (en) 1995-12-07 2002-04-09 Diversa Corporation Screening for novel bioactivities
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US6171820B1 (en) 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US6238884B1 (en) 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US6361974B1 (en) 1995-12-07 2002-03-26 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US6352842B1 (en) 1995-12-07 2002-03-05 Diversa Corporation Exonucease-mediated gene assembly in directed evolution
US6489145B1 (en) 1996-07-09 2002-12-03 Diversa Corporation Method of DNA shuffling
US6358709B1 (en) 1995-12-07 2002-03-19 Diversa Corporation End selection in directed evolution
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US5851804A (en) 1996-05-06 1998-12-22 Apollon, Inc. Chimeric kanamycin resistance gene
US5877001A (en) 1996-06-17 1999-03-02 Diverso Corporation Amidase
US5763239A (en) 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
JPH1066576A (ja) 1996-08-07 1998-03-10 Novo Nordisk As 突出末端を有する２本鎖ｄｎａ及びこれを用いたｄｎａのシャフリング方法
WO1998013485A1 (en) 1996-09-27 1998-04-02 Maxygen, Inc. Methods for optimization of gene therapy by recursive sequence shuffling and selection
JP2001504325A (ja) 1996-09-27 2001-04-03 マキシジェン，インコーポレイテッド 回帰的配列シャフリングおよび選択による遺伝子治療の最適化のための方法
US5925544A (en) 1996-11-18 1999-07-20 Novo Nordisk A/S Method of homologous recombination followed by in vivo selection of DNA amplification
EP0948615B1 (en) 1996-12-20 2004-12-15 Novozymes A/S In vivo recombination
DE69835360T2 (de) 1997-01-17 2007-08-16 Maxygen, Inc., Redwood City EVOLUTION Prokaryotischer GANZER ZELLEN DURCH REKURSIVE SEQUENZREKOMBINATION
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
AU6029998A (en) 1997-01-17 1998-08-07 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
US6159687A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods for generating recombined polynucleotides
CN1249784A (zh) 1997-03-18 2000-04-05 诺沃挪第克公司 一种体外构建dna文库的方法
ATE418608T1 (de) 1997-03-18 2009-01-15 Novozymes As Methode zur herstellung einer bibliothek mittels dna-shuffling
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
US6291165B1 (en) 1997-03-18 2001-09-18 Novo Nordisk A/S Shuffling of heterologous DNA sequences
ATE468394T1 (de) 1997-03-18 2010-06-15 Novozymes As Vermischen von heterologen dns-sequenzen
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
GB9712512D0 (en) * 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
AU1124499A (en) 1997-10-28 1999-05-17 Maxygen, Inc. Human papillomavirus vectors
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
CA2315944A1 (en) 1997-12-24 1999-07-08 Diatech Pty. Ltd. Bifunctional molecules
JP2002507393A (ja) 1998-02-11 2002-03-12 マキシジェン， インコーポレイテッド 抗原ライブラリー免疫
US20010006950A1 (en) 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
CA2320431A1 (en) 1998-02-11 1999-08-19 Maxygen, Inc. Targeting of genetic vaccine vectors
AUPP221098A0 (en) 1998-03-06 1998-04-02 Diatech Pty Ltd V-like domain binding molecules
WO1999057128A1 (en) 1998-05-01 1999-11-11 Maxygen, Inc. Optimization of pest resistance genes using dna shuffling
US6562622B1 (en) 1998-05-08 2003-05-13 Diatech Pty, Ltd Continuous in vitro evolution
WO1999065927A2 (en) 1998-06-17 1999-12-23 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
FR2782323B1 (fr) 1998-08-12 2002-01-11 Proteus Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues
US20020059659A1 (en) 1998-08-12 2002-05-16 Maxygen, Inc. DNA shuffling to produce herbicide selective crops
KR20010083077A (ko) 1998-08-12 2001-08-31 추후제출 제초제 선택성 작물을 생성하는 ｄｎａ 재편성
AU5696899A (en) 1998-08-31 2000-03-21 Maxygen, Inc. Transformation, selection, and screening of sequence-shuffled polynucleotides for development and optimization of plant phenotypes
IL140441A0 (en) 1998-09-29 2002-02-10 Maxygen Inc Shuffling of codon altered genes
WO2000020573A2 (en) 1998-10-07 2000-04-13 Maxygen, Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
WO2000028017A1 (en) 1998-11-10 2000-05-18 Maxygen, Inc. Modified phosphoenolpyruvate carboxylase for improvement and optimization of plant phenotypes
JP2002529079A (ja) 1998-11-10 2002-09-10 マキシジェン， インコーポレイテッド 改変されたリブロース１，５−ビスホスフェートカルボキシラーゼ／オキシゲナーゼ
WO2000028018A1 (en) 1998-11-10 2000-05-18 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes
FR2786787B1 (fr) 1998-12-08 2002-04-19 Proteus Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
US6358712B1 (en) 1999-01-05 2002-03-19 Trustee Of Boston University Ordered gene assembly
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU2415200A (en) 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
JP2002534966A (ja) 1999-01-19 2002-10-22 マキシジェン， インコーポレイテッド オリゴヌクレオチド媒介核酸組換え
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
CA2361927A1 (en) 1999-03-09 2000-09-14 Diversa Corporation End selection in directed evolution
AU4039400A (en) 1999-03-26 2000-10-16 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
WO2000061740A1 (en) 1999-04-10 2000-10-19 Maxygen, Inc. Modified lipid production
AU4456200A (en) 1999-04-13 2000-11-14 Maxygen, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
WO2000072013A1 (en) 1999-05-21 2000-11-30 The Penn State Research Foundation Construction of incremental truncation libraries
US7332308B1 (en) 1999-05-21 2008-02-19 The Penn State Research Foundation Incrementally truncated nucleic acids and methods of making same
CA2374347A1 (en) 1999-05-31 2000-12-07 Novozymes A/S Screening method for peptides
WO2001000234A2 (en) 1999-06-25 2001-01-04 Maxygen, Inc. Methods and compositions for engineering of attenuated vaccines
WO2001002865A1 (en) 1999-07-06 2001-01-11 Maxygen, Inc. Cyclotron mass spectrometry screening
WO2001004287A1 (en) 1999-07-07 2001-01-18 Maxygen Aps A method for preparing modified polypeptides
IL147384A0 (en) 1999-08-12 2002-08-14 Maxygen Inc Dna shuffling of dioxygenase genes for production of industrial chemicals
AU8001300A (en) 1999-10-07 2001-05-10 Maxygen, Inc. Ifn-alpha homologues
IL148439A0 (en) 1999-10-13 2002-09-12 Univ Leland Stanford Junior Biosynthesis of polyketide synthase substrates
AU1456101A (en) 1999-11-03 2001-05-14 Maxygen, Inc. Antibody diversity generation
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
AU1799801A (en) 1999-11-23 2001-06-04 Maxygen, Inc. Homologous recombination in plants
AU1800401A (en) 1999-11-23 2001-06-04 Maxygen, Inc. Shuffling of agrobacterium and viral genes, plasmids and genomes for improved plant transformation
EP1238068A1 (en) 1999-12-08 2002-09-11 California Institute Of Technology Directed evolution of biosynthetic and biodegration pathways
US20020042055A1 (en) 1999-12-23 2002-04-11 Affholter Joseph A. Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions
EP1276900A2 (en) 2000-01-11 2003-01-22 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US6329178B1 (en) 2000-01-14 2001-12-11 University Of Washington DNA polymerase mutant having one or more mutations in the active site
WO2001064864A2 (en) 2000-02-28 2001-09-07 Maxygen, Inc. Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation
US20020155571A1 (en) 2000-02-29 2002-10-24 Raillard Sun Ai Triazine degrading enzymes
WO2001068803A2 (en) 2000-03-02 2001-09-20 Maxygen, Inc. Enzymes, pathways and organisms for making a polymerizable monomer by whole cell bioprocess
WO2001070947A2 (en) 2000-03-20 2001-09-27 Maxygen, Inc. Method for generating recombinant dna molecules in complex mixtures
AU2001287273A1 (en) 2000-03-24 2001-10-08 Maxygen, Inc. Methods for modulating cellular and organismal phenotypes
EP1272967A2 (en) 2000-03-30 2003-01-08 Maxygen, Inc. In silico cross-over site selection
US6902922B2 (en) 2000-04-03 2005-06-07 Novozymes A/S Subtilisin variants
AU2001266978A1 (en) 2000-06-14 2001-12-24 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
WO2002004629A2 (en) 2000-07-07 2002-01-17 Maxygen, Inc. Molecular breeding of transposable elements
US20020102577A1 (en) 2000-07-31 2002-08-01 Raillard Sun Ai Nucleotide incorporating enzymes
FR2813314B1 (fr) 2000-08-25 2004-05-07 Biomethodes Procede de mutagenese dirigee massive
AU2001292711A1 (en) 2000-09-18 2002-03-26 Genetic Therapy, Inc. Stress resistant retroviruses
WO2002029032A2 (en) 2000-09-30 2002-04-11 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
AU2001274635A1 (en) * 2000-11-10 2002-05-21 Amicogen, Inc. Method for generating recombinant dna library using unidirectional single-stranded dna fragments
JP4430303B2 (ja) * 2000-12-12 2010-03-10 アリゲーター・バイオサイエンス・アーベー タンパク質機能のインビトロ分子進化方法
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function

Also Published As

Publication number Publication date
ES2285118T5 (es) 2012-09-21
EP1504098B2 (en) 2011-02-09
EP1504098B1 (en) 2007-03-14
AU2003230027A1 (en) 2003-12-02
DK200401821A (da) 2004-11-23
CA2485506C (en) 2012-02-28
WO2003097834A2 (en) 2003-11-27
US20060166198A1 (en) 2006-07-27
CA2485506A1 (en) 2003-11-27
DE60312507D1 (de) 2007-04-26
AU2003230027A8 (en) 2003-12-02
US7262012B2 (en) 2007-08-28
WO2003097834A3 (en) 2004-02-19
ATE356871T1 (de) 2007-04-15
JP2005525820A (ja) 2005-09-02
DE60312507T2 (de) 2007-12-06
ES2285118T3 (es) 2007-11-16
DE60312507T3 (de) 2011-08-18
JP4372679B2 (ja) 2009-11-25
EP1504098A2 (en) 2005-02-09
DK1504098T4 (da) 2011-05-23

Similar Documents

Publication Publication Date Title
DK1504098T3 (da) Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
ATE258982T1 (de) Verfahren zur herstellung von hantelförmigen dna- molekülen als expressionskonstrukte
ATE419388T1 (de) Nukleinsäureanreicherung
JP2019518476A (ja) 等温核酸自己増幅法
ATE295882T1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
ATE409235T1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
ATE469984T1 (de) Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
ATE540110T1 (de) Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt
NO20016428D0 (no) Fremgangsmåter for kloning og fremstilling av fragmentkjeder med lesbart informasjonsinnhold
WO2002083943A3 (de) Mikroarray-verfahren zur anreicherung von dna-fragmenten aus komplexen mischungen
JP2004515248A5 (da)
DE60219632D1 (de) Verfahren zur herstellung von matrizen-dna und verfahren zur proteinherstellung in einem zellfreien proteinsynthesesystem unter verwendung davon
DE69928409D1 (de) Methode zur bestimmung von polynukleotidsequenzvariationen
WO2003016550A3 (en) Compositions and methods comprising control nucleic acid
DK1948794T3 (da) Fremgangsmåde til molekylær evolution in vitro af proteinfunktion
EP3643788A1 (en) Pcr primer pair and application thereof
ATE420975T1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
ATE346165T1 (de) Verfahren zur trennung und/oder erkennung von dns-molekülen
ATE417938T1 (de) Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner
DE60217972D1 (de) Methode zur erhöhung der effizienz von enzymatischen aufreinigungsprozessen
ATE299929T1 (de) Biotechnologisches verfahren zur herstellung von n-acetylmannosamin
WO2004016757A3 (en) Methods, compositions and kits for producing nucleic and acid sequences
AU2002317939A1 (en) Improved methods relating to amplification-based analysis of DNA